Literature DB >> 2982945

Activated human B cells display a functional IL 2 receptor.

R Mittler, P Rao, G Olini, E Westberg, W Newman, M Hoffmann, G Goldstein.   

Abstract

These studies deal with the expression of a functional IL 2 receptor on activated primary human B cells. Antibody against the receptor (alpha-TAC) reacted with 25 to 65% activated B cells, inhibited B cell proliferation by 50% and inhibited B cell secretion of Ig by greater than 90%. These effects were shown to be independent of contaminating T lymphocytes. Anti-TAC immunoprecipitated a molecule of identical size (65,000 daltons) from T and B lymphocytes; B cells were also shown to actively synthesize the IL 2 receptor. The chymotryptic peptide chromatograms of TAC antigen from T and B cells show these molecules to be indistinguishable.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982945

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Airway generation-specific differences in the spatial distribution of immune cells and cytokines in allergen-challenged rhesus monkeys.

Authors:  L A Miller; S D Hurst; R L Coffman; N K Tyler; M Y Stovall; D L Chou; L F Putney; L J Gershwin; E S Schelegle; C G Plopper; D M Hyde
Journal:  Clin Exp Allergy       Date:  2005-07       Impact factor: 5.018

2.  Expression of Tac antigen in B cell lymphomas.

Authors:  G Laurent; T Al Saati; D Olive; J C Laurent; P Poncelet; G Delsol
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts.

Authors:  Lucinda J Berglund; Danielle T Avery; Cindy S Ma; Leen Moens; Elissa K Deenick; Jacinta Bustamante; Stephanie Boisson-Dupuis; Melanie Wong; Stephen Adelstein; Peter D Arkwright; Rosa Bacchetta; Liliana Bezrodnik; Harjit Dadi; Chaim M Roifman; David A Fulcher; John B Ziegler; Joanne M Smart; Masao Kobayashi; Capucine Picard; Anne Durandy; Matthew C Cook; Jean-Laurent Casanova; Gulbu Uzel; Stuart G Tangye
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

4.  Interleukin-2 may enhance or inhibit antibody production by B cells depending on intracellular cAMP concentrations.

Authors:  D Dennig; S Mecheri; J H Bourhis; M K Hoffman
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

5.  T-cell abnormality and defective interleukin-2 production in patients with carcinoma of the urinary bladder with schistosomiasis.

Authors:  S Raziuddin; S Shetty; A Ibrahim
Journal:  J Clin Immunol       Date:  1991-03       Impact factor: 8.317

6.  Cloning, sequence, and expression of bovine interleukin 2.

Authors:  D P Cerretti; K McKereghan; A Larsen; M A Cantrell; D Anderson; S Gillis; D Cosman; P E Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells.

Authors:  M Callaghan; A Whelan; C Feighery; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Interleukin-2 inhibits the interleukin-4-induced human IgE and IgG4 secretion in vivo.

Authors:  H L Spiegelberg; R J Falkoff; R D O'Connor; L Beck
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

9.  Direct induction of human B-cell differentiation by recombinant interleukin-2.

Authors:  S Romagnani; G Del Prete; M G Giudizi; R Biagiotti; F Almerigogna; A Tiri; A Alessi; M Mazzetti; M Ricci
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

10.  T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2.

Authors:  A M Draeger; A J Swaak; H G van den Brink; L A Aarden
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.